Key result
NIP-141 inhibited the transient outward current and the ultra-rapid delayed rectifier K current in human atrial myocytes with half-maximal inhibition concentrations of 16.3 microM and 5.3 microM.
Why the study?
Does NIP-141 inhibit K currents in isolated human atrial myocytes?
Does NIP-141 inhibit K currents in isolated human atrial myocytes?
NIP-141 inhibits transient outward and ultra-rapid delayed rectifier K currents in human atrial myocytes, suggesting a mechanism for terminating atrial fibrillation by prolonging action potential duration.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for NIP-141 in AF; in vivo studies needed before clinical consideration.
A novel benzopyran derivative, NIP-141, effectively terminates experimental atrial fibrillation in canine hearts by prolonging atrial refractoriness. However, the effects of this drug on human atrial myocytes are unknown. This experiment evaluated the effects of NIP-141 on K currents in isolated human atrial myocytes using a whole-cell voltage-clamp method. NIP-141 inhibited the transient outward current (I(to)) and the ultra-rapid delayed rectifier K current (I(Kur)), each in a dose-dependent manner, with half-maximal inhibition concentrations of 16.3 microM and 5.3 microM, respectively (n = 5). NIP-141 inhibited both K currents in a voltage- and use-independent fashion, and it preferentially blocked them in the open state and dissociated rapidly from the channel. Because both K currents contribute significantly to the repolarization of the atrial action potential, these findings suggest that NIP-141 may terminate atrial fibrillation by prolonging action potential duration.
No takes yet. Share an insight, caveat, or question.
Seki et al. (2002) studied Atrial fibrillation (n=5). NIP-141 was evaluated on Inhibition of transient outward current (I(to)) and ultra-rapid delayed rectifier K current (I(Kur)) (IC50 16.3 microM for I(to) and 5.3 microM for I(Kur)). NIP-141 inhibited the transient outward current and the ultra-rapid delayed rectifier K current in human atrial myocytes with half-maximal inhibition concentrations of 16.3 microM and 5.3 microM.
Synapse has enriched 10 related papers. Consider them for comparative context: